Documents Disclosures

* The Safety and Efficacy Of Cangrelor, a Short Acting, IV, Reversible, Platelet P2Y12 Inhibitor In Patients Awaiting Cardiac Surgery: Results Of the BRIDGE Trial Dominick…

Documents 1 The Safety and Efficacy Of Cangrelor, a Short Acting, IV, Reversible, Platelet P2Y 12 Inhibitor In...

Slide 1 1 The Safety and Efficacy Of Cangrelor, a Short Acting, IV, Reversible, Platelet P2Y 12 Inhibitor In Patients Awaiting Cardiac Surgery: Results Of the BRIDGE Trial…